Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY-NC-SAJournal of Atherosclerosis and Thrombosis

A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification

Abstract

Waist circumference (WC) is widely used as a marker of central obesity in the diagnosis of metabolic syndrome (MetS) and it plays an important role in cardiovascular disease (CVD) risk screening. In Japan, the MetS diagnostic criteria established in 2005 require abdominal obesity as a mandatory component, with WC cutoff values of 85 cm for men and 90 cm for women. These criteria are also applied in the national Specific Health Checkup and Specific Health Guidance programs to identify individuals at a high risk of CVD. However, the scientific basis and clinical implications of these thresholds remain controversial.This review summarizes the epidemiological evidence on WC cutoff values in the Japanese population and their relevance to CVD risk. A literature search of PubMed and Ichushi-Web identified studies examining WC thresholds in relation to visceral fat accumulation, clustering of cardiometabolic risk factors, and incident CVD. The evidence was organized into four themes: (1) WC cutoffs based on visceral fat area, (2) prediction of cardiometabolic risk factor clustering, (3) the association between WC and incident CVD, and (4) associations between MetS definitions and CVD risk.Available evidence suggests that the WC thresholds corresponding to visceral fat accumulation and cardiometabolic risk clustering are generally lower than the current Japanese criterion for women. Prospective studies examining WC alone have reported inconsistent associations with incident CVD, particularly among women. Overall, the evidence suggests that CVD risk stratification frameworks requiring abdominal obesity based on WC thresholds may have limitations. Future screening strategies in Japan may benefit from greater emphasis on clustering and the overall burden of cardiometabolic risk factors.

Related

  1. NMR metabolomics for cardiovascular-kidney-metabolic risk stratification in an integrated healthcare system
    J. Chacon-Barahona, C. Iribarren, J. S. Rana +6
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  2. Adipocytokine Profiling and Cardiovascular Risk Stratification in Rheumatoid Arthritis: Literature Review
    Abdalla Elsayed, Abdulrahman Ismaiel, Mihai Bojinca
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  3. Exerkines in Cardiovascular–Kidney–Metabolic Syndrome: An Integrative Framework for Mechanisms and Therapeutic Implications—A Narrative Review
    Hongyan Fan, Changlin Zhai, Chaojie He +3
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Lipoprotein(a) and Risk Stratification for Atherosclerotic Cardiovascular Disease Across the Cardiovascular‐Kidney‐Metabolic Continuum
    Yanwen Fang, Xuyan Pei, Sizhuang Huang +5
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDSurgery & anaesthesiaCrossref
  5. A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study
    Zhengyang Zhu, Kejun Ren, Dong Wang +4
    PLOS MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineEndocrinology & metabolismPLOS
BibTeX
@article{uchida2026literature,
  title = {{A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification}},
  author = {Tomoe Uchida and Aya Hirata},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  month = aug,
  doi = {10.5551/jat.rv22051},
  url = {https://www.jstage.jst.go.jp/article/jat/33/8/33_RV22051/_article},
  note = {CC BY-NC-SA},
}
RIS
TY  - JOUR
TI  - A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification
AU  - Tomoe Uchida
AU  - Aya Hirata
PY  - 2026
DA  - 2026/08/01
JO  - Journal of Atherosclerosis and Thrombosis
DO  - 10.5551/jat.rv22051
UR  - https://www.jstage.jst.go.jp/article/jat/33/8/33_RV22051/_article
AB  - Waist circumference (WC) is widely used as a marker of central obesity in the diagnosis of metabolic syndrome (MetS) and it plays an important role in cardiovascular disease (CVD) risk screening. In Japan, the MetS diagnostic criteria established in 2005 require abdominal obesity as a mandatory component, with WC cutoff values of 85 cm for men and 90 cm for women. These criteria are also applied in the national Specific Health Checkup and Specific Health Guidance programs to identify individuals at a high risk of CVD. However, the scientific basis and clinical implications of these thresholds remain controversial.This review summarizes the epidemiological evidence on WC cutoff values in the Japanese population and their relevance to CVD risk. A literature search of PubMed and Ichushi-Web identified studies examining WC thresholds in relation to visceral fat accumulation, clustering of cardiometabolic risk factors, and incident CVD. The evidence was organized into four themes: (1) WC cutoffs based on visceral fat area, (2) prediction of cardiometabolic risk factor clustering, (3) the association between WC and incident CVD, and (4) associations between MetS definitions and CVD risk.Available evidence suggests that the WC thresholds corresponding to visceral fat accumulation and cardiometabolic risk clustering are generally lower than the current Japanese criterion for women. Prospective studies examining WC alone have reported inconsistent associations with incident CVD, particularly among women. Overall, the evidence suggests that CVD risk stratification frameworks requiring abdominal obesity based on WC thresholds may have limitations. Future screening strategies in Japan may benefit from greater emphasis on clustering and the overall burden of cardiometabolic risk factors.
SN  - 1880-3873
SN  - 1340-3478
ER  -